Rheumatic diseases Musculoskeletal Diseases Arthropathies
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Pilot study: 1.1. Patients with rheumatic diseases 1.2. Aged 20 to 70 1.3. Minimum disease duration one year 2. Main study: 2.1. Patients with inflammatory rheumatic diseases 2.2. Age 20 to 65 2.3. Minimum disease duration one year
Exclusion criteria
Exclusion criteria: 1. Pilot study: not speaking Norwegian language 2. Main study: 2.1. Not speaking Norwegian language 2.2. Non-inflammatory diagnosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Psychological Distress (General Health Questionnaire 20), this will be measured repeatedly five times before the intervention, five times after the intervention and five times one year after the intervention 2. Self-Efficacy (Arthritis Self-Efficacy Scale), this will be measured one time before the intervention (baseline), one time immediately after the intervention and at one year follow-up (12 months after baseline) 3. Emotional Approach Coping (Emotional Approach Coping Scale), this will be measured one time before the intervention (baseline), one time immediately after the intervention and at one year follow-up (12 months after baseline) | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptoms: pain, fatigue, disease activity (Visual Analogue Score [VAS]-scales), this will be measured repeatedly five times before the intervention, five times after the intervention and five times one year after the intervention. Additionally, patient characteristics of age, gender, civil status, work status, diagnosis, disease duration, drug use and use of health care will be collected at baseline. All data will be collected by self-reported questionnaires. | — |
Countries
Norway